ANVS
Price
$2.40
Change
+$0.02 (+0.84%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
45.99M
41 days until earnings call
CRBP
Price
$7.71
Change
-$0.04 (-0.52%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
94.35M
Interact to see
Advertisement

ANVS vs CRBP

Header iconANVS vs CRBP Comparison
Open Charts ANVS vs CRBPBanner chart's image
Annovis Bio
Price$2.40
Change+$0.02 (+0.84%)
VolumeN/A
Capitalization45.99M
Corbus Pharmaceuticals Holdings
Price$7.71
Change-$0.04 (-0.52%)
Volume$4.99K
Capitalization94.35M
ANVS vs CRBP Comparison Chart in %
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. CRBP commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a StrongBuy and CRBP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ANVS: $2.36 vs. CRBP: $7.71)
Brand notoriety: ANVS and CRBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 42% vs. CRBP: 49%
Market capitalization -- ANVS: $45.99M vs. CRBP: $94.35M
ANVS [@Biotechnology] is valued at $45.99M. CRBP’s [@Biotechnology] market capitalization is $94.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileCRBP’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • CRBP’s FA Score: 0 green, 5 red.
According to our system of comparison, both ANVS and CRBP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while CRBP’s TA Score has 5 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 4 bearish.
  • CRBP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ANVS and CRBP are a good buy in the short-term.

Price Growth

ANVS (@Biotechnology) experienced а +8.76% price change this week, while CRBP (@Biotechnology) price change was -3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ANVS is expected to report earnings on Aug 13, 2025.

CRBP is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($94.3M) has a higher market cap than ANVS($46M). CRBP YTD gains are higher at: -34.661 vs. ANVS (-53.082). ANVS has higher annual earnings (EBITDA): -25.17M vs. CRBP (-48.74M). CRBP has more cash in the bank: 133M vs. ANVS (22.2M). ANVS (0) and CRBP (0) have equivalent revenues.
ANVSCRBPANVS / CRBP
Capitalization46M94.3M49%
EBITDA-25.17M-48.74M52%
Gain YTD-53.082-34.661153%
P/E RatioN/AN/A-
Revenue00-
Total Cash22.2M133M17%
Total DebtN/A2.86M-
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSCRBP
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSHRF0.290.01
+2.24%
Goldshore Resources Inc.
AMDUF80.95N/A
N/A
AMUNDI SA
MOHCF23.00N/A
N/A
Motor Oil (Hellas) Corinth Refineries S.A.
ENNPF17.40N/A
N/A
Enbridge Inc.
SIUDF0.04N/A
N/A
Shanghai Industrial Urban Development Group Ltd.

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-0.84%
ADXN - ANVS
43%
Loosely correlated
+2.68%
MDGL - ANVS
36%
Loosely correlated
-0.43%
EWTX - ANVS
33%
Poorly correlated
+0.15%
VTYX - ANVS
32%
Poorly correlated
+2.97%
AXON - ANVS
31%
Poorly correlated
+2.70%
More

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-0.52%
SKYE - CRBP
46%
Loosely correlated
+23.26%
FBIO - CRBP
38%
Loosely correlated
+2.73%
STOK - CRBP
37%
Loosely correlated
-0.61%
APLS - CRBP
35%
Loosely correlated
+2.47%
CCCC - CRBP
30%
Poorly correlated
-2.63%
More